$340.00
Today −0.27%Quote Oct 19, 2026, 08:00 PM UTC
+10.11%over the last month
Max drawdown −5.1%From 1-month high −0.4%3 months +12.2%
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Cencora, Inc. functions as a global leader in the sourcing and distribution of pharmaceutical products, with operations spanning both the United States and international markets. Within its U.S. Healthcare Solutions segment, the company supplies a broad spectrum of pharmaceutical items, including generic and injectable medications, over-the-counter health products, and home healthcare equipment.
Q3 2026 revenue $84.79B
Sector
Healthcare
Industry
Medical - Distribution
Exchange
NYSE
Employees
49,000
Founded
1871
Market value
$64.88B
Quote Oct 19
Floor
$336.67
1.0% below price
Resistance
$345.64
1.7% above price
The price is close to the lowest analyst target. Analysts' average target sits about 4% higher.
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free